FBRX – Forte Biosciences Inc
FBRX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
11.54
Margin Of Safety %
Put/Call OI Ratio
2.88
EPS Next Q Diff
0.52
EPS Last/This Y
0.88
EPS This/Next Y
-0.2
Price
76.8
Target Price
73.8
Analyst Recom
2.6
Performance Q
193.43
Upside
-186.5%
Beta
2.63
Ticker: FBRX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | FBRX | 44.2 | 6.57 | 4.40 | 2431 |
| 2026-07-14 | FBRX | 43.36 | 7.04 | 999.99 | 2550 |
| 2026-07-15 | FBRX | 44.04 | 7.42 | 4.53 | 2661 |
| 2026-07-16 | FBRX | 44.92 | 7.52 | 6.68 | 2725 |
| 2026-07-17 | FBRX | 48.82 | 7.41 | 6.75 | 2724 |
| 2026-07-20 | FBRX | 47.53 | 4.39 | 7.70 | 1212 |
| 2026-07-21 | FBRX | 50.59 | 4.70 | 1.78 | 1248 |
| 2026-07-22 | FBRX | 56.59 | 4.51 | 16.50 | 1283 |
| 2026-07-23 | FBRX | 59.65 | 4.70 | 0.19 | 1346 |
| 2026-07-24 | FBRX | 54.8 | 1.66 | 54.56 | 1835 |
| 2026-07-27 | FBRX | 76.53 | 1.87 | 59.38 | 2005 |
| 2026-07-28 | FBRX | 76.65 | 6.73 | 2.10 | 5519 |
| 2026-07-29 | FBRX | 76.5 | 5.04 | 0.38 | 5696 |
| 2026-07-30 | FBRX | 76.98 | 2.93 | 10.33 | 6602 |
| 2026-07-31 | FBRX | 76.61 | 2.95 | 0.42 | 6653 |
| 2026-08-03 | FBRX | 76.6 | 2.22 | 16.56 | 7098 |
| 2026-08-04 | FBRX | 76.55 | 2.22 | 16.27 | 7109 |
| 2026-08-05 | FBRX | 76.61 | 2.88 | 13.20 | 8593 |
| 2026-08-07 | FBRX | 76.79 | 2.88 | 999.99 | 9059 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | FBRX | 44.10 | -4.9 | - | -4.01 |
| 2026-07-14 | FBRX | 43.28 | -4.9 | - | -4.01 |
| 2026-07-15 | FBRX | 44.02 | -4.9 | - | -4.01 |
| 2026-07-16 | FBRX | 45.01 | -4.9 | - | -4.01 |
| 2026-07-17 | FBRX | 48.77 | -4.9 | - | -4.01 |
| 2026-07-20 | FBRX | 47.53 | -4.9 | - | -4.01 |
| 2026-07-21 | FBRX | 50.53 | -4.9 | - | -4.01 |
| 2026-07-22 | FBRX | 56.54 | -4.9 | - | -4.01 |
| 2026-07-23 | FBRX | 59.66 | -4.9 | - | -4.01 |
| 2026-07-24 | FBRX | 54.66 | -4.9 | - | -4.01 |
| 2026-07-27 | FBRX | 76.53 | 5.5 | - | -3.89 |
| 2026-07-28 | FBRX | 76.59 | 5.5 | - | -3.89 |
| 2026-07-29 | FBRX | 76.56 | 5.5 | - | -3.89 |
| 2026-07-30 | FBRX | 76.96 | 5.5 | - | -3.83 |
| 2026-07-31 | FBRX | 76.60 | 8.5 | - | -3.83 |
| 2026-08-03 | FBRX | 76.60 | 8.5 | - | -3.83 |
| 2026-08-04 | FBRX | 76.60 | 8.5 | - | -3.83 |
| 2026-08-05 | FBRX | 76.60 | 8.5 | - | -3.83 |
| 2026-08-06 | FBRX | 76.80 | 8.5 | - | -3.83 |
| 2026-08-07 | FBRX | 76.80 | 8.5 | - | -3.83 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | FBRX | 0.00 | 17.17 | 10.60 |
| 2026-07-14 | FBRX | 0.00 | 17.17 | 10.60 |
| 2026-07-15 | FBRX | 0.00 | 17.17 | 10.60 |
| 2026-07-16 | FBRX | 0.00 | 17.17 | 10.60 |
| 2026-07-17 | FBRX | 0.00 | 17.17 | 10.60 |
| 2026-07-20 | FBRX | 0.00 | 17.23 | 10.60 |
| 2026-07-21 | FBRX | 0.00 | 17.23 | 10.60 |
| 2026-07-22 | FBRX | 0.00 | 17.23 | 10.60 |
| 2026-07-23 | FBRX | 0.00 | 17.23 | 10.60 |
| 2026-07-24 | FBRX | 0.00 | 17.23 | 10.60 |
| 2026-07-27 | FBRX | 0.00 | 15.40 | 11.55 |
| 2026-07-28 | FBRX | 0.00 | 15.40 | 11.55 |
| 2026-07-29 | FBRX | 0.00 | 15.40 | 11.55 |
| 2026-07-30 | FBRX | 0.00 | 15.40 | 11.55 |
| 2026-07-31 | FBRX | 0.00 | 15.40 | 11.55 |
| 2026-08-03 | FBRX | 0.00 | 23.67 | 11.55 |
| 2026-08-04 | FBRX | 0.00 | 23.67 | 11.55 |
| 2026-08-05 | FBRX | 0.00 | 23.67 | 11.54 |
| 2026-08-06 | FBRX | 0.00 | 23.67 | 11.54 |
| 2026-08-07 | FBRX | 0.00 | 23.67 | 11.54 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.45
Avg. EPS Est. Current Quarter
-0.88
Avg. EPS Est. Next Quarter
-0.93
Insider Transactions
Institutional Transactions
23.67
Beta
2.63
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
5
Growth Score
18
Sentiment Score
81
Actual DrawDown %
90.2
Max Drawdown 5-Year %
-99.4
Target Price
73.8
P/E
Forward P/E
PEG
P/S
P/B
25.37
P/Free Cash Flow
EPS
-5.11
Average EPS Est. Cur. Y
-3.83
EPS Next Y. (Est.)
-4.04
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.03
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.18
EBIT Estimation
◆
FBRX
Healthcare
$76.79
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
84.7
Range 1M
99.3%
Sup Dist
0%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
18.6%
EPS NY
-5.3%
52W%
99.4%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-3.9% upside
Upside
-3.9%
Quality
5
FBRX — P/E HistoricalBiotechnology
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 22
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
FBRX
Latest News
—
Caricamento notizie per FBRX…
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading